Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion type Assertion NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_head.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion description "[The aims of this study were to develop a reliable hepatic metastatic colonic cancer model in mice using the intraportal route for injection, with follow-up by bioluminescence (BLI) and to evaluate the impact of tumor location on tumor antigen direct targeting using radiolabeled anti-CEA (carcinoembryonic antigen) antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_provenance.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion evidence source_evidence_literature NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_provenance.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion SIO_000772 21116205 NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_provenance.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion wasDerivedFrom befree-2016 NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_provenance.
- NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_assertion wasGeneratedBy ECO_0000203 NP855637.RAyTu4GueKk-PukMsl8gn9Gj3_YT0ve6c9fY2yrW_p5P0130_provenance.